Oncology & Cancer

Genomic tug of war could boost cancer therapy

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant ...

page 2 from 7